Stockholder derivativesuits are intended to allow a corporation to recover funds from unfaithful directors, not to punish directors for the wrongdoing of corporate employees.
Other shareholder derivativesuits motivated by the federal settlement have been filed against Pfizer, and several have been consolidated in a New York federal court.
Lawyers bringing derivativesuits, as opposed to shareholder class actions on behalf of investors who suffered losses, must go through a bit of a Kabuki dance before they get their money.